Skip to content
Use caution Drug recall · FDA · Published April 2, 2015

Roxane Recalls Acarbose 50mg Tablets Due to Low Potency

Roxane Laboratories recalls specific lots of Acarbose 50mg tablets because potency was found to be below specification during stability testing.

🇺🇸 FDA recall #D-1085-2015DrugRoxane Laboratories ›
Take action

Contact the company

Recalling firmBoehringer Ingelheim Roxane Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

Roxane Laboratories, Inc. is recalling specific lots of Acarbose Tablets 50 mg because the drug's potency was found to be lower than required specifications. This issue was identified when the firm received out-of-specification results for assay at the nine-month stability time point. The recall affects both unit dose blister packs and 100-count bottles distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/44816-boehringer-ingelheim-roxane-inc-recalls-acarbose-tablets-50-mg-a.

Source Summary by GovInfoNow · govinfonow.com/recall/44816-boehringer-ingelheim-roxane-inc-recalls-acarbose-tablets-50-mg-a · Updated October 12, 2026 · FDA enforcement record: FDA #D-1085-2015

Cite this page

“Roxane Recalls Acarbose 50mg Tablets Due to Low Potency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44816-boehringer-ingelheim-roxane-inc-recalls-acarbose-tablets-50-mg-a. Based on FDA recall #D-1085-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1085-2015%22&limit=1).

Boehringer Ingelheim Roxane Inc voluntarily recalled Acarbose Tablets 50 mg on April 2, 2015, after the FDA announced the drugs were subpotent due to out-of-specification assay results. The recall affects specific lots distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: Roxane Laboratories
  • Product: Acarbose Tablets 50 mg
  • NDC: 0054-0141-20 (10 x 10 Unit Dose Tablets per Blister Pack)
  • NDC: 0054-0141-25 (100 count Bottles)
  • Lot # 460073A Exp 04/2016
  • Lot # 460073B Exp 04/2016

The hazard

The firm received an out of specification result for Assay, meaning potency was below specification at the 9 month stability time point. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include Apotex Paxil CR 37.5mg Tablets Recall: Failed Stability Testing (2026-08-13), AvKARE Rosuvastatin Tablets 10mg Recall: Dissolution Issue (2025-12-31), and Ascend Laboratories recalls Amlodipine/Olmesartan tablets with low drug content (2026-07-08).

How to tell if you have this one

Check your medication for the following details: Brand Roxane Laboratories, NDC 0054-0141-20 (10 x 10 Unit Dose Tablets per Blister Pack) or NDC 0054-0141-25 (100 count Bottles). The affected lots are #460073A and #460073B, both with an expiration date of 04/2016.

  • Brand
    Roxane Laboratories
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if you have Acarbose Tablets 50 mg from Roxane Laboratories with NDCs 0054-0141-20 or 0054-0141-25 and lots 460073A or 460073B.

  2. Contact your pharmacist

    If you have the recalled product, speak with your pharmacist or healthcare provider to discuss replacement options or further instructions.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Apr 2, 201512. FDA classified it Class II: May 27, 201523. Published in FDA’s Enforcement Report: Jun 3, 201532015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1085-2015 (April 2, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1085-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA